FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2897766727> ?p ?o ?g. }

• W2897766727 endingPage "6994" @default.
• W2897766727 startingPage "6988" @default.
• W2897766727 abstract "Abstract Introduction Respiratory syncytial virus (RSV) is the single most important cause of severe respiratory illness in infants. There is no effective vaccine and the only effective treatment available is the monoclonal antibody palivizumab which reduces the risk of severe RSV disease in prematurely born infants. However, palivizumab is too costly to allow for wide implementation and thus treatment is restricted to supportive care. Despite extensive efforts to develop a vaccine, progress has been hindered by the difficulty in measuring and assessing immunological correlates of RSV vaccine efficacy in the presence of high levels of pre-existing RSV antibodies. Methods Here we describe a new method for measuring the functional activity of antibodies induced by vaccination distinct from pre-existing antibodies. Antibodies in lymphocyte supernatants (ALS) from the cultured peripheral blood mononuclear cells (PBMCs) of young adults who had recently been vaccinated with a novel RSV candidate vaccine were directly assayed for virus neutralising activity. An ELISA method was used to measure antibodies in nasal and serum samples and then compared with the adapted ALS based method. Results There was a wide background distribution of RSV-specific antibodies in serum and nasal samples that obscured vaccine-specific responses measured two weeks after vaccination. No RSV-specific antibodies were observed at baseline in ALS samples, but a clear vaccine-specific antibody response was observed in ALS seven days after the administration of each dose of vaccine. These vaccine-specific antibodies in ALS displayed functional activity in vitro, and quantification of this functional activity was unperturbed by pre-existing antibodies from natural exposure. The results demonstrate a promising new approach for assessing functional immune responses attributed to RSV vaccines." @default.
• W2897766727 created "2018-10-26" @default.
• W2897766727 creator A5007023755 @default.
• W2897766727 creator A5014344703 @default.
• W2897766727 creator A5020716782 @default.
• W2897766727 creator A5024501463 @default.
• W2897766727 creator A5030593366 @default.
• W2897766727 creator A5044421583 @default.
• W2897766727 creator A5058147481 @default.
• W2897766727 creator A5065914659 @default.
• W2897766727 creator A5090057576 @default.
• W2897766727 date "2018-11-01" @default.
• W2897766727 modified "2023-09-26" @default.
• W2897766727 title "Antibodies in lymphocyte supernatants can distinguish between neutralising antibodies induced by RSV vaccination and pre-existing antibodies induced by natural infection" @default.
• W2897766727 cites W1547768824 @default.
• W2897766727 cites W1592061050 @default.
• W2897766727 cites W1824053132 @default.
• W2897766727 cites W1947623111 @default.
• W2897766727 cites W1971057004 @default.
• W2897766727 cites W1989501142 @default.
• W2897766727 cites W1994149977 @default.
• W2897766727 cites W1998562109 @default.
• W2897766727 cites W2006371327 @default.
• W2897766727 cites W2012861532 @default.
• W2897766727 cites W2020830257 @default.
• W2897766727 cites W2028532590 @default.
• W2897766727 cites W2031567249 @default.
• W2897766727 cites W2032603724 @default.
• W2897766727 cites W2048617927 @default.
• W2897766727 cites W2049701596 @default.
• W2897766727 cites W2052337358 @default.
• W2897766727 cites W2056663174 @default.
• W2897766727 cites W2078168327 @default.
• W2897766727 cites W2097382676 @default.
• W2897766727 cites W2099201161 @default.
• W2897766727 cites W2103353840 @default.
• W2897766727 cites W2107897726 @default.
• W2897766727 cites W2116002381 @default.
• W2897766727 cites W2120949068 @default.
• W2897766727 cites W2125065061 @default.
• W2897766727 cites W2125262390 @default.
• W2897766727 cites W2130715267 @default.
• W2897766727 cites W2141031524 @default.
• W2897766727 cites W2141475184 @default.
• W2897766727 cites W2145445974 @default.
• W2897766727 cites W2151007400 @default.
• W2897766727 cites W2156780978 @default.
• W2897766727 cites W2164616921 @default.
• W2897766727 cites W2169665123 @default.
• W2897766727 cites W2171765255 @default.
• W2897766727 cites W2193720945 @default.
• W2897766727 cites W2228382949 @default.
• W2897766727 cites W2606043757 @default.
• W2897766727 cites W573823033 @default.
• W2897766727 doi "https://doi.org/10.1016/j.vaccine.2018.09.070" @default.
• W2897766727 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7116660" @default.
• W2897766727 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30318168" @default.
• W2897766727 hasPublicationYear "2018" @default.
• W2897766727 type Work @default.
• W2897766727 sameAs 2897766727 @default.
• W2897766727 citedByCount "0" @default.
• W2897766727 crossrefType "journal-article" @default.
• W2897766727 hasAuthorship W2897766727A5007023755 @default.
• W2897766727 hasAuthorship W2897766727A5014344703 @default.
• W2897766727 hasAuthorship W2897766727A5020716782 @default.
• W2897766727 hasAuthorship W2897766727A5024501463 @default.
• W2897766727 hasAuthorship W2897766727A5030593366 @default.
• W2897766727 hasAuthorship W2897766727A5044421583 @default.
• W2897766727 hasAuthorship W2897766727A5058147481 @default.
• W2897766727 hasAuthorship W2897766727A5065914659 @default.
• W2897766727 hasAuthorship W2897766727A5090057576 @default.
• W2897766727 hasBestOaLocation W28977667272 @default.
• W2897766727 hasConcept C137061746 @default.
• W2897766727 hasConcept C159047783 @default.
• W2897766727 hasConcept C159654299 @default.
• W2897766727 hasConcept C202751555 @default.
• W2897766727 hasConcept C203014093 @default.
• W2897766727 hasConcept C22070199 @default.
• W2897766727 hasConcept C2522874641 @default.
• W2897766727 hasConcept C2777761686 @default.
• W2897766727 hasConcept C2778644256 @default.
• W2897766727 hasConcept C542903549 @default.
• W2897766727 hasConcept C55493867 @default.
• W2897766727 hasConcept C71924100 @default.
• W2897766727 hasConcept C86803240 @default.
• W2897766727 hasConcept C8891405 @default.
• W2897766727 hasConceptScore W2897766727C137061746 @default.
• W2897766727 hasConceptScore W2897766727C159047783 @default.
• W2897766727 hasConceptScore W2897766727C159654299 @default.
• W2897766727 hasConceptScore W2897766727C202751555 @default.
• W2897766727 hasConceptScore W2897766727C203014093 @default.
• W2897766727 hasConceptScore W2897766727C22070199 @default.
• W2897766727 hasConceptScore W2897766727C2522874641 @default.
• W2897766727 hasConceptScore W2897766727C2777761686 @default.
• W2897766727 hasConceptScore W2897766727C2778644256 @default.
• W2897766727 hasConceptScore W2897766727C542903549 @default.
• W2897766727 hasConceptScore W2897766727C55493867 @default.
• W2897766727 hasConceptScore W2897766727C71924100 @default.

• next